cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Merck Co Inc
279 own
159 watching
Current Price
$127.5
$-1.98
(-1.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
279,931.74M
52-Week High
52-Week High
133.10001
52-Week Low
52-Week Low
99.14000
Average Volume
Average Volume
7.76M
Dividend Yield
Dividend Yield
0.031859
P/E Ratio
P/E Ratio
28.6667
iconMarket Capitalization279,931.74M
icon52-Week High133.10001
icon52-Week Low99.14000
iconAverage Volume7.76M
iconDividend Yield0.031859
iconP/E Ratio28.6667
What does the Merck Co Inc do?
Merck & Co., Inc. provides healthcare solutions worldwide. It operates in four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances segments. The company offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal infections, intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases. It also offers neuromuscular blocking agents; anti-bacterial products; cholesterol modifying medicines; and vaginal contraceptive products. In addition, the company offers products to prevent chemotherapy-induced and post-operative nausea and vomiting; treat brain tumors; treat melanoma and metastatic non-small-cell lung cancer; prevent diseases caused by human papillomavirus; and vaccines for measles, mumps, rubella, varicella, chickenpox, shingles, rotavirus gastroenteritis, and pneumococcal diseases. Further, it offers antibiotic and anti-inflammatory drugs to treat infectious and respiratory diseases, fertility disorders, and pneumonia in cattle, horses, and swine; vaccines for poultry; parasiticide for sea lice in salmon; and antibiotics and vaccines for fishes. Additionally, the company offers companion animal products, such as ointments for acute and chronic otitis; diabetes mellitus treatment for dogs and cats; anthelmintic products; fluralaner products to treat fleas and ticks in dogs; and products for protection against bites from fleas, ticks, mosquitoes, and sandflies. It serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Read More
How much money does Merck Co Inc make?
News & Events about Merck Co Inc.
Globe Newswire
12 months ago
Essential Pharma appoints Lee Morley as Non-Executive Director to the Board Zug, Switzerland & Egham, UK 21 June 2023 Essential Pharma, an international specialty pharma group focused on ensuring that patients have sustainable access to low volume, clinically well-established pharmaceutical products...
Ticker Report
1 year ago
Builder Investment Group Inc. ADV bought a new stake in Merck Co., Inc. (NYSE:MRK Get Rating) in the fourth quarter, HoldingsChannel reports. The firm bought 7,743 shares of the companys stock, valued at approximately $859,000. A number of other institutional investors and hedge...
Ticker Report
1 year ago
ST Germain D J Co. Inc. lifted its stake in Merck Co., Inc. (NYSE:MRK Get Rating) by 39.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor owned 52,516 shares of the company&#...
Accesswire
1 year ago
NORTHAMPTON, MA / ACCESSWIRE / June 16, 2023 / Merck & Co., Inc.In underserved and under-resourced communities across the globe, from the U.S. to Rwanda, our company is helping patients at risk for and living with cancer access the care they need to stay well and lead fulfilling lives.We...
Business Wire
1 year ago
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the Phase 3 KEYNOTE-811 trial investigating KEYTRUDA, Mercks anti-PD-1 therapy, in combination with trastuzumab and chemotherapy met one of its dual primary endpoints of progression-free survival (PFS) for...
Frequently Asked Questions
Frequently Asked Questions
What is Merck Co Inc share price today?
plus_minus_icon
Can Indians buy Merck Co Inc shares?
plus_minus_icon
How can I buy Merck Co Inc shares from India?
plus_minus_icon
Can Fractional shares of Merck Co Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Merck Co Inc stocks?
plus_minus_icon
What is today’s traded volume of Merck Co Inc?
plus_minus_icon
What is today’s market capitalisation of Merck Co Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Merck Co Inc?
plus_minus_icon
What percentage is Merck Co Inc down from its 52-Week High?
plus_minus_icon
What percentage is Merck Co Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$127.5
$-1.98
(-1.53%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00